These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4141048)

  • 21. [Clinical experiences with phyto-therapy of benign prostatic hypertrophy].
    Bauer KM
    Med Welt; 1980 Aug; 31(34):1211-4. PubMed ID: 6159518
    [No Abstract]   [Full Text] [Related]  

  • 22. [Medical treatment of prostatic adenoma. Urinary flow data].
    Giglio V; Campo B; Motta M
    Minerva Urol; 1972; 24(3):104-7. PubMed ID: 4141047
    [No Abstract]   [Full Text] [Related]  

  • 23. [Raveron treatment of prostatic adenoma in the light of uroflowmetry (on the basis of 20 cases)].
    Janosz F; Zieliński J
    Pol Przegl Chir; 1975 Nov; 47(11A):1441-4. PubMed ID: 54910
    [No Abstract]   [Full Text] [Related]  

  • 24. [Regression of the symptoms of prostatic adenomas. Results of 6 months' conservative treatment using ERU capsules].
    Maar K
    Fortschr Med; 1987 Jan; 105(1):18-20. PubMed ID: 2435642
    [No Abstract]   [Full Text] [Related]  

  • 25. [Conservative therapy of prostatic hyperplasia with urinary retention].
    Djulepa J
    Med Welt; 1983 Dec; 34(48):1377-9. PubMed ID: 6197601
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs. placebo].
    Tasca A; Barulli M; Cavazzana A; Zattoni F; Artibani W; Pagano F
    Minerva Urol Nefrol; 1985; 37(1):87-91. PubMed ID: 2413558
    [No Abstract]   [Full Text] [Related]  

  • 27. [Extracts Serenoa repens in the treatment of prostatic adenoma and chronic abacterial prostatitis: results of short-term (3-month courses) therapy].
    Aliaev IuG; Vinarov AZ; Lokshin KL; Spivak LG
    Urologiia; 2007; (2):80-2. PubMed ID: 17578203
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of prostatic hypertrophy with eviprostat].
    Kubo Y; Inoue S; Ono T; Yasui A
    Hinyokika Kiyo; 1966 Dec; 12(12):1463-7. PubMed ID: 4167083
    [No Abstract]   [Full Text] [Related]  

  • 29. [Efficacy and safety of prostamol-UNO in the treatment of patients with initial symptoms of prostatic adenoma and risk of progression: 2 years of investigations].
    Aliaev IuG; Apolikhin OI; Mazo EB; Vinarov AZ; Lokshin KL; Medvedev AA; Permiakova OV; Spivak LG; Shkol'nikov ME
    Urologiia; 2009; (4):36-40. PubMed ID: 19824382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gestonorone therapy of prostatic adenoma].
    Lopatkin N; Darenkow A; Sahmatow J; Tankó A; Ignaschin N; Warentsow G
    Acta Chir Acad Sci Hung; 1980; 21(4):271-8. PubMed ID: 6175122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herbal Rx for prostate problems.
    Consum Rep; 2000 Sep; 65(9):60-2. PubMed ID: 11503703
    [No Abstract]   [Full Text] [Related]  

  • 32. [Changes in the echostructure of prostatic adenomas during drug therapy].
    Szutrely HP
    Med Klin Prax; 1982 Aug; 77(18):42-6. PubMed ID: 6182449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prostatic adenoma. The conservative therapy with urtica extract].
    Barsom S; Bettermann AA
    ZFA (Stuttgart); 1979 Nov; 55(33):1947-50. PubMed ID: 93356
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of prostamol-Uno on oxidative and local immune status in patients with benign prostatic hyperplasia and chronic prostatitis].
    Seregin SP; Bratchikov OI; Konoplia AI; Shestakov SG; Dolzhenkov SD; Novikov AV; Shatokhin MN; Kotov AV
    Urologiia; 2002; (4):14-6. PubMed ID: 12357892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Safety of continuous (more than 1 year) intake of Serenoa repens extract by patients with prostatic adenoma].
    Vinarov AZ; Aliaev IuG; Lokshin KL
    Urologiia; 2009; (1):84, 86-7. PubMed ID: 19432240
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prostamol-uno in the treatment of benign prostatic hyperplasia].
    Razumov SV; Derevianko II; Sivkov AV
    Urologiia; 2001; (2):35-7. PubMed ID: 11490715
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of benign prostatic hyperplasia. Results of a treatment study with the phytogenic combination of Sabal extract WS 1473 and Urtica extract WS 1031 in urologic specialty practices].
    Schneider HJ; Honold E; Masuhr T
    Fortschr Med; 1995 Jan; 113(3):37-40. PubMed ID: 7534258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia].
    Song Y; Li NC; Wang XF; Ma LL; Wan B; Hong BF; Na YQ
    Zhonghua Nan Ke Xue; 2005 Sep; 11(9):674-6. PubMed ID: 16209208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plant extracts: sense or nonsense?
    Madersbacher S; Berger I; Ponholzer A; Marszalek M
    Curr Opin Urol; 2008 Jan; 18(1):16-20. PubMed ID: 18090484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical experience with oxendolone for treatment of benign prostatic hyperplasia. Clinical efficacy and effects on serum lipid and lipoprotein fraction levels].
    Yasukawa A; Nihira H; Matsuki S; Fujii M; Fujiwara H; Kitano T; Kodama M; Ukai R; Tado O; Sagami K
    Hinyokika Kiyo; 1984 Apr; 30(4):537-43. PubMed ID: 6207714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.